全球呼吸道融合細胞病毒診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計呼吸道融合細胞病毒診斷市場將從 2025 年的 72.3 億美元成長到 2034 年的 122.9 億美元，2026 年至 2034 年的複合年成長率為 6.07%。

全球呼吸道融合細胞病毒）診斷市場正蓬勃發展，尤其得益於人們對嬰幼兒和老年人RSV感染疾病的認知不斷提高。季節性疫情爆發和監測系統的完善推動了對快速、準確診斷檢測的需求。醫療機構正優先考慮早期檢測，以減少住院人數並有效控制疾病傳播。

對感染疾病診斷投入的增加和分子檢測技術的進步正在推動市場成長。就地檢驗盒和多重檢測方法的開發提高了診斷效率。政府疫苗接種計劃和公共衛生宣傳活動進一步支持了全球範圍內的防控意識提升和早期篩檢工作。

展望未來，技術創新將在市場形成過程中發揮關鍵作用。快速分子診斷和攜帶式檢測設備的整合將提高偏遠地區的檢測可及性。在全球對感染疾病防治日益關注的背景下，呼吸道融合細胞病毒診斷市場預計將持續擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球呼吸道融合細胞病毒診斷市場：依產品分類

• 市場分析、洞察與預測
• 直接螢光測定法（DFA）
• 快速抗原診斷檢測（RADT）
• 分子診斷
• 層析法免疫分析法
• 診斷影像
• 凝膠微滴法
• 流式細胞技術
• 其他

第5章 全球呼吸道融合細胞病毒診斷市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 測試機構
• 診所
• 居家照護

第6章 全球呼吸道融合細胞病毒診斷市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 亞太其他地區
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Novartis AG
  • Abbott
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • BIOMRIEUX
  • DiaSorin SPA
  • Merck KGaA
  • Coris BioConcept
  • Siemens Healthcare SA
  • Quest Diagnostics Incorporated

The Respiratory Syncytial Virus Diagnostics Market size is expected to reach USD 12.29 Billion in 2034 from USD 7.23 Billion (2025) growing at a CAGR of 6.07% during 2026-2034.

The Global Respiratory Syncytial Virus Diagnostics Market is gaining momentum due to increasing awareness about RSV infections, particularly among infants and elderly populations. Seasonal outbreaks and improved surveillance systems are driving demand for rapid and accurate diagnostic tests. Healthcare providers are prioritizing early detection to reduce hospitalizations and manage disease spread effectively.

Rising investments in infectious disease diagnostics and advancements in molecular testing technologies are strengthening market growth. The development of point-of-care testing kits and multiplex assays has improved diagnostic efficiency. Government vaccination initiatives and public health campaigns are further supporting awareness and early screening efforts worldwide.

Looking ahead, technological innovation will play a pivotal role in shaping the market. Integration of rapid molecular diagnostics and portable testing devices will enhance accessibility in remote areas. As global focus on infectious disease preparedness intensifies, the RSV diagnostics market is expected to witness sustained expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Direct Fluorescent Antibody (DFA) Method
• Rapid Antigen Diagnostic Test (RADTs)
• Molecular Diagnostics
• Chromatographic Immunoassa
• Diagnostic Imaging
• Gel Microdroplets
• Flow Cytometry
• Others

By End Use

• Hospitals
• Laboratory
• Clinics
• Homecare

COMPANIES PROFILED

• BD Becton Dickinson Company, , Novartis AG, Abbott, QuidelOrtho Corporation, Thermo Fisher Scientific Inc, BioRad Laboratories Inc, F HoffmannLa Roche Ltd, BIOMRIEUX, DiaSorin SpA, Merck KGaA, Coris BioConcept, Siemens Healthcare SA, Quest Diagnostics Incorporated
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Direct Fluorescent Antibody (DFA) Method Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Rapid Antigen Diagnostic Test (RADTs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Chromatographic Immunoassa Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Diagnostic Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Gel Microdroplets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Flow Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Laboratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Novartis AG
  • 8.2.2 Abbott
  • 8.2.3 QuidelOrtho Corporation
  • 8.2.4 Thermo Fisher Scientific Inc
  • 8.2.5 Bio-Rad Laboratories Inc
  • 8.2.6 F. Hoffmann-La Roche Ltd
  • 8.2.7 BIOMRIEUX
  • 8.2.8 DiaSorin S.P.A
  • 8.2.9 Merck KGaA
  • 8.2.10 Coris BioConcept
  • 8.2.11 Siemens Healthcare S.A
  • 8.2.12 Quest Diagnostics Incorporated